Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Comparing hip surgery with and without fluoroscopy

Official title: A Randomized, Monocentric Investigator-initiated Clinical Investigation Comparing Fluoroscopy Versus Freehand in Total Hip Arthroplasty

Run by Ente Ospedaliero Cantonale, Bellinzona · NCT05653687 · Data updated 2026-11-12

This study is testing whether using a special imaging technique during hip surgery leads to better placement of the hip implant and improved recovery for patients compared to the traditional method.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment84 (estimated)
SponsorEnte Ospedaliero Cantonale, Bellinzona
Academic / other
Locations1 site (Lugano, Canton Ticino)
StatusRecruiting
StartedMay 22, 2023
Main results expectedMarch 2028
Study endsMarch 2028
Registry record updatedSeptember 11, 2026
Trial IDNCT05653687 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients aged 18-90 undergoing unilateral primary total hip arthroplasty.

Probably not a fit

Patients undergoing revision hip arthroplasty or those with significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to compare the outcomes of total hip arthroplasty performed with intraoperative fluoroscopy versus the traditional freehand method. The focus is on evaluating the positioning of the hip prosthesis by analyzing post-operative X-rays. By assessing the accuracy of prosthesis placement, the study seeks to determine if fluoroscopy enhances surgical precision and improves patient outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved accuracy in hip prosthesis placement, potentially reducing complications and enhancing recovery for patients.

How similar studies have gone: Previous studies have shown that intraoperative imaging techniques can improve surgical outcomes, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing unilateral primary THA through DAA
* Patients aged 18-90 years old.
* Patients with a BMI \>18 and \<35.
* Patients able to provide informed consent.
* Informed consent as documented by signature.

Exclusion Criteria:

* Revision THA.
* Women who are pregnant or breast feeding.
* Presence of other clinically significant concomitant disease states (ASA IV).
* Previous enrolment into the current study.
* Enrolment of the investigator, his/her family members, employees and other dependent persons.

Where it's running

  • Ente Ospedaliero Cantonale
    Lugano, Canton Ticino, Switzerland
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.